Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIORA THERAPEUTICS, INC. (PROG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 746800.0% | 777300.0% | 17458.8% | 13763.5% | 18705.6% | | 16891.8% | 7800.4% |
| Sales and marketing | | | | | | 73.8% | | |
| Research and development | | | | | | | | |
| General and administrative | | | | | | | | |
| EBITDA | -874050.0% | -911950.0% | -20822.5% | -5083.7% | -22400.0% | -10669.9% | -18124.2% | -7091.4% |
| Depreciation | 8300.0% | 7350.0% | 252.5% | 216.3% | 300.9% | 85.7% | 54.4% | 112.3% |
| EBIT | -882350.0% | -919300.0% | -21075.0% | -5300.0% | -22700.9% | -10755.6% | -18178.6% | -7203.7% |
| Pre-tax income | -890150.0% | -872050.0% | -18395.0% | -6571.2% | -13542.1% | -19058.6% | -20260.4% | -8941.7% |
| Income taxes | 200.0% | 0.0% | 197.5% | -804.8% | -637.4% | -13545.5% | 0.0% | 0.0% |
| Net income | -890350.0% | -872050.0% | -6392.5% | -5301.0% | -12904.7% | -21350.1% | -24035.2% | -16961.3% |
|